Document is current
Any future updates will be listed below
-
Authors
Xiao, Sophia
Freeman, Ashley
Kalmanek, Emily
Steckly, Kelsey
Belding-Schmitt, Mary
Chan, Carlos H.F.
Talbert, Erin E. https://orcid.org/0000-0003-4587-0950
-
Funding
Funding for this research was provided by:
National Institutes of Health (R21CA257972)
National Institutes of Health (R21CA257972)
National Cancer Institute (P30 CA086862)
National Cancer Institute (P30 CA086862)
National Center for Advancing Translational Sciences (UM1TR004403)
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 15 September 2025
First Online: 29 December 2025
Declarations
:
: Patients with cancer receiving care at the University of Iowa Health Care are approached to consent to research under the PERCH (Patients Enhancing Research Collaboration at Holden) program at the Holden Comprehensive Cancer Center. Gastrointestinal cancer patients consent to PERCH through the Gastrointestinal Molecular Epidemiology Resource, which has been approved by the University of Iowa Institutional Review Board (IRB # 201202742, first approved February 21, 2012). The research herein was conducted with the data of patients who provided informed consent to participate PERCH and related research. This specific research was approved under a waiver of consent by the University of Iowa Institutional Review Board (IRB # 202101083, first approved July 9, 2021), with appropriate protections of patient privacy in compliance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
